Candida Auris, An Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?
Open accessThe DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
The emergence of Candida auris is considered as one of the most serious problems associated with nosocomial transmission and with infection control practices in hospital environment. This multidrug resistant species is rapidly spreading worldwide, with several described outbreaks. Until now, this species has been isolated from different hospital surfaces, where it can survive for long periods. There are multiple unanswered questions regarding C. auris, such as prevalence in population, environmental contamination, effectiveness of infection prevention and control, and impact on patient mortality. In order to understand how it spreads and discover possible reservoirs, it is essential to know the ecology, natural environment, and distribution of this species. It is also important to explore possible reasons to this recent emergence, namely the environmental presence of azoles or the possible effect of climate change on this sudden emergence. This review aims to discuss some of the most challenging issues that we need to have in mind in the management of C. auris and to raise the awareness to its presence in specific indoor environments as hospital settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Global epidemiology of Candida auris for November 2019 (image adapted from CDC [19]). Single cases were reported from Austria, Belgium, Chile, Italy, Greece, Egypt, Iran, Norway, Switzerland, Taiwan and United Arab Emirates. Multiple cases and extensive hospital transmission were reported from Australia, Bangladesh, Canada, China, Colombia, France, Germany, India, Israel, Japan, Kenya, Kuwait, Malaysia, Paskistan, Netherlands, Oman, Panama, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, UK, USA and Venezuela [20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35].](https://figures.cochat.ai/paper-figures/4489f155c1184d219817a98397ed29a5/candida-auris-an-agent-of-hospital-associated-outbreaks-which-challenging-issues-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multi-drug resistant Candida infections are on the rise due to a variety of mechanisms (Table 2), particularly C. auris, with widespread azole resistance and the potential for development of resistance to all classes of antifungals during therapy, highlighting the need for new agents to keep up with changes in epidemiology.133,145–153”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [151]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · cited 4×
“auris has been isolated from can help to differentiate between simple colonization and infection [89].”
BackgroundInfluentialEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 2×
“Invasive candidiasis may be caused by more than 150 Candida species [3].”
BackgroundSiegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848 · cited 1×
“Candida species are adapted to surface adherence and biofilms formation in body surfaces as well prosthetic devices, including urinary catheters and intravascular devices [72].”
BackgroundLockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662 · cited 7×
“auris isolates from the different regions (East Asia, South Asia, Africa, and South America) [11].”
BackgroundInfluentialSatoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., & Yamaguchi, H. (2009) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00083.x · Cited by 1,381 · cited 1×
“auris was first described in 2009, after being isolated from the external ear canal of an inpatient in a Japanese hospital [5].”
BackgroundPappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1194 · Cited by 1,298
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
First hospital outbreak of the globally emerging Candida auris in a European hospital
Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768 · cited 5×
“auris isolates from an outbreak in a cardio‐thoracic center located in the United Kingdom with other isolates from other countries in order to identify a geographic origin of the ongoing outbreak [39].”
BackgroundInfluentialChowdhary, A., Sharma, C., & Meis, J. F. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006290 · Cited by 750 · cited 3×
“Resistance is probably inducible under antifungal pressure, resulting in rapid mutational changes [64].”
BackgroundInfluentialEpidemiology and risk factors for invasive candidiasis
Yapar, N. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s40160 · Cited by 610 · cited 1×
“albicans, the most frequent etiological agent [1].”
BackgroundCandida auris: a Review of the Literature
Jeffery-Smith, A., Taori, S. K., Schelenz, S., Jeffery, K., Johnson, E. M., Borman, A., Candida auris Incident Management Team, Manuel, R., & Brown, C. S. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-17 · Cited by 595
Chowdhary, A., Prakash, A., Sharma, C., Kordalewska, M., Kumar, A., Sarma, S., Tarai, B., Singh, A., Upadhyaya, G., Upadhyay, S., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx480 · Cited by 577
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576 · cited 1×
“albicans to transition between yeast and filamentous forms is a key virulence trait that is triggered by a wide variety of environmental cues [70].”
BackgroundFluconazole resistance in Candida species: a current perspective
Berkow, E., & Lockhart, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s118892 · Cited by 542 · cited 2×
“auris can exhibit a rate of resistance to fluconazole as high as 93% [4].”
BackgroundFirst Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
Lee, W. G., Shin, J. H., Uh, Y., Kang, M. G., Kim, S. H., Park, K. H., & Jang, H.-C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00319-11 · Cited by 523 · cited 2×
“auris infections, including fungemia, wound infections and otitis, have been most commonly identified [6].”
BackgroundA Candida auris Outbreak and Its Control in an Intensive Care Setting
Eyre, D. W., Sheppard, A. E., Madder, H., Moir, I., Moroney, R., Quan, T. P., Griffiths, D., George, S., Butcher, L., Morgan, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714373 · Cited by 517 · cited 2×
“auris outbreak in an intensive care setting, the risk for colonization or infection was associated with exposure to axillary temperature monitoring [7].”
BackgroundOn the emergence of Candida auris: climate change, azoles, swamps, and birds
Casadevall, A., Kontoyiannis, D. P., & Robert, V. (2019) · mBio · doi:10.1128/mbio.01397-19 · Cited by 515
Muñoz, J. F., Gade, L., Chow, N. A., Loparev, V. N., Juieng, P., Berkow, E. L., Farrer, R. A., Litvintseva, A. P., & Cuomo, C. A. (2018) · Nature Communications · doi:10.1038/s41467-018-07779-6 · Cited by 458 · cited 11×
“Molecular methods are also being applied to detect resistance in C. auris using allele‐specific molecular beacons and DNA melting curve analysis following asymmetric PCR. A duplex ERG11 assay and a simplex FKS1 HS1 assay were developed to identify the most prominent resistance‐ associated mutations concerning resistan…”
BackgroundInfluentialCalvo, B., Melo, A. S. A., Perozo-Mena, A., Hernandez, M., Francisco, E. C., Hagen, F., Meis, J. F., & Colombo, A. L. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.07.008 · Cited by 448
Candida auris : The recent emergence of a multidrug-resistant fungal pathogen
Forsberg, K., Woodworth, K., Walters, M., Berkow, E. L., Jackson, B., Chiller, T., & Vallabhaneni, S. (2019) · Medical Mycology · doi:10.1093/mmy/myy054 · Cited by 421
Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris
Sherry, L., Ramage, G., Kean, R., Borman, A., Johnson, E. M., Richardson, M. D., & Rautemaa-Richardson, R. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2302.161320 · Cited by 420
New Clonal Strain of Candida auris, Delhi, India
Chowdhary, A., Sharma, C., Duggal, S., Agarwal, K., Prakash, A., Singh, P. K., Jain, S., Kathuria, S., Randhawa, H. S., Hagen, F., et al. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1910.130393 · Cited by 418
Larkin, E., Hager, C., Chandra, J., Mukherjee, P. K., Retuerto, M., Salem, I., Long, L., Isham, N., Kovanda, L., Borroto-Esoda, K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02396-16 · Cited by 395 · cited 1×
“auris, suggesting alternative pathways regarding the yeast‐to‐filament transition between the two Candida species [71].”
BackgroundCandida auris: an Emerging Fungal Pathogen
Spivak, E. S., & Hanson, K. E. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01588-17 · Cited by 393 · cited 3×
“Stewardship teams can also assist with rapid case identification, appropriate management, and coordinate with infection prevention to minimize transmission [12].”
BackgroundMultidrug-resistant endemic clonal strain of Candida auris in India
Chowdhary, A., Anil Kumar, V., Sharma, C., Prakash, A., Agarwal, K., Babu, R., Dinesh, K. R., Karim, S., Singh, S. K., Hagen, F., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-2027-1 · Cited by 373
Candida auris candidaemia in Indian ICUs: analysis of risk factors
Rudramurthy, S. M., Chakrabarti, A., Paul, R. A., Sood, P., Kaur, H., Capoor, M. R., Kindo, A. J., Marak, R. S. K., Arora, A., Sardana, R., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx034 · Cited by 357 · cited 3×
“The majority of the reported infections involved critically ill patients [14].”
BackgroundPotential Fifth Clade of Candida auris, Iran, 2018
Chow, N. A., de Groot, T., Badali, H., Abastabar, M., Chiller, T. M., & Meis, J. F. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2509.190686 · Cited by 356 · cited 3×
“auris population consists of distinct clades that harbour nearly identical strains within each clade (East Asia, South Asia, Africa, and South America) [11,13].”
BackgroundRuiz‐Gaitán, A., Moret, A. M., Tasias‐Pitarch, M., Aleixandre‐López, A. I., Martínez‐Morel, H., Calabuig, E., Salavert‐Lletí, M., Ramírez, P., López‐Hontangas, J. L., Hagen, F., et al. (2018) · Mycoses · doi:10.1111/myc.12781 · Cited by 343
Borman, A. M., Szekely, A., & Johnson, E. M. (2016) · mSphere · doi:10.1128/msphere.00189-16 · Cited by 333
Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris
Cortegiani, A., Misseri, G., Fasciana, T., Giammanco, A., Giarratano, A., & Chowdhary, A. (2018) · Journal of Intensive Care · doi:10.1186/s40560-018-0342-4 · Cited by 329 · cited 1×
“haemulonii and one was not identified to species level [9,10].”
BackgroundMechanisms of echinocandin antifungal drug resistance
Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313 · cited 1×
“These mutations correspond to known mutations in other Candida species, which have been directly linked to echinocandin resistance [66].”
BackgroundKim, M., Shin, J. H., Sung, H., Lee, K., Kim, E., Ryoo, N., Lee, J., Jung, S., Park, K. H., Kee, S. J., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/597108 · Cited by 309 · cited 1×
“Almost half of isolates are multidrug‐resistant (resistant to ≥ 2 antifungal classes), and a low number (4%) exhibit resistance to all classes of antifungals [11,14,91].”
BackgroundVallabhaneni, S., Kallen, A., Tsay, S., Chow, N., Welsh, R., Kerins, J., Kemble, S. K., Pacilli, M., Black, S. R., Landon, E., et al. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6544e1 · Cited by 302
Osei Sekyere, J. (2018) · MicrobiologyOpen · doi:10.1002/mbo3.578 · Cited by 300 · cited 5×
“auris present frequently several underlying health conditions or comorbidities (diabetes, chronic/acute kidney failure/pathologies, immunosuppression conditions, solid tumour/malignancies, cardiovascular diseases, and liver diseases) [43].”
BackgroundInfluentialMcCarty, T. P., & Pappas, P. G. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.013 · Cited by 285 · cited 1×
“However, over the last two decades, invasive candidiasis is emerging in critically ill patients, due to several factors such as aging populations with many comorbidities, extended stays in hospital wards, diabetes, use of invasive devices, broad‐spectrum antibiotics, extensive surgeries, stem cell transplantation, and…”
BackgroundCandida auris in Healthcare Facilities, New York, USA, 2013–2017
Adams, E., Quinn, M., Tsay, S., Poirot, E., Chaturvedi, S., Southwick, K., Greenko, J., Fernandez, R., Kallen, A., Vallabhaneni, S., et al. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2410.180649 · Cited by 284 · cited 2×
“auris is an emerging microorganism, with proven high ability to spread and multidrug resistance that makes it an epidemiologically important microorganism that in addition to basic infection control measures requires the implementation of contact precautions of infection control [49,50].”
BackgroundCandida auris–Associated Candidemia, South Africa
Magobo, R. E., Corcoran, C., Seetharam, S., & Govender, N. P. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2007.131765 · Cited by 259
Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris
Chatterjee, S., Alampalli, S. V., Nageshan, R. K., Chettiar, S. T., Joshi, S., & Tatu, U. S. (2015) · BMC Genomics · doi:10.1186/s12864-015-1863-z · Cited by 247
Vallabhaneni, S., Kallen, A., Tsay, S., Chow, N., Welsh, R., Kerins, J., Kemble, S. K., Pacilli, M., Black, S. R., Landon, E., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14121 · Cited by 247 · cited 2×
“auris infections is significantly higher in patients with primary or acquired immunosuppression, secondary to therapeutic management of hematologic malignancies, bone marrow transplantation, and other condition requiring immunosuppressive agents [18,39].”
BackgroundGenomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris
Rhodes, J., Abdolrasouli, A., Farrer, R. A., Cuomo, C. A., Aanensen, D. M., Armstrong-James, D., Fisher, M. C., & Schelenz, S. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0045-x · Cited by 246
Invasive Infections with Multidrug-Resistant Yeast Candida auris , Colombia
Morales-López, S. E., Parra-Giraldo, C. M., Ceballos-Garzón, A., Martínez, H. P., Rodríguez, G. J., Álvarez-Moreno, C. A., & Rodríguez, J. Y. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2301.161497 · Cited by 243
Biswal, M., Rudramurthy, S. M., Jain, N., Shamanth, A. S., Sharma, D., Jain, K., Yaddanapudi, L. N., & Chakrabarti, A. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.09.009 · Cited by 223
Escandón, P., Chow, N. A., Caceres, D. H., Gade, L., Berkow, E. L., Armstrong, P., Rivera, S., Misas, E., Duarte, C., Moulton-Meissner, H., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy411 · Cited by 222 · cited 2×
“albicans and a membrane transporter [45].”
BackgroundCan Multidrug-Resistant Candidaauris Be Reliably Identified in Clinical Microbiology Laboratories?
Mizusawa, M., Miller, H., Green, R., Lee, R., Durante, M., Perkins, R., Hewitt, C., Simner, P. J., Carroll, K. C., Hayden, R. T., et al. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02202-16 · Cited by 217
Sharma, C., Kumar, N., Pandey, R., Meis, J. F., & Chowdhary, A. (2016) · New Microbes and New Infections · doi:10.1016/j.nmni.2016.07.003 · Cited by 202 · cited 1×
“auris isolates from four Indian hospitals were highly related and their findings were suggestive of clonal transmission [37].”
BackgroundKordalewska, M., Zhao, Y., Lockhart, S. R., Chowdhary, A., Berrio, I., & Perlin, D. S. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00630-17 · Cited by 195
The first isolate of Candida auris in China: clinical and biological aspects
Wang, X., Bing, J., Zheng, Q., Zhang, F., Liu, J., Yue, H., Tao, L., Du, H., Wang, Y., Wang, H., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0095-0 · Cited by 191 · cited 3×
“Interestingly, a small portion of highly elongated and pseudohyphae‐like forms were observed when grown on YPD plus 10% NaCl [68].”
BackgroundInfluentialCandida auris Candidemia in Kuwait, 2014
Emara, M., Ahmad, S., Khan, Z., Joseph, L., Al-Obaid, I., Purohit, P., & Bafna, R. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2106.150270 · Cited by 184
Candida auris: Disinfectants and Implications for Infection Control
Ku, T. S. N., Walraven, C. J., & Lee, S. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00726 · Cited by 177
Yue, H., Bing, J., Zheng, Q., Zhang, Y., Hu, T., Du, H., Wang, H., & Huang, G. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0187-x · Cited by 176 · cited 1×
“auris has been reported which transits cells in three different cell types—typical yeast, filamentation-competent yeast and filamentous cells [69].”
BackgroundLeach, L., Zhu, Y., & Chaturvedi, S. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01223-17 · Cited by 169
Prakash, A., Sharma, C., Singh, A., Kumar Singh, P., Kumar, A., Hagen, F., Govender, N. P., Colombo, A. L., Meis, J. F., & Chowdhary, A. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.10.022 · Cited by 167
On the Origins of a Species: What Might Explain the Rise of Candida auris?
Jackson, B. R., Chow, N., Forsberg, K., Litvintseva, A. P., Lockhart, S. R., Welsh, R., Vallabhaneni, S., & Chiller, T. (2019) · Journal of Fungi · doi:10.3390/jof5030058 · Cited by 162
Nosocomial fungemia by Candida auris: First four reported cases in continental Europe
Ruiz Gaitán, A. C., Moret, A., López Hontangas, J. L., Molina, J. M., Aleixandre López, A. I., Cabezas, A. H., Mollar Maseres, J., Arcas, R. C., Gómez Ruiz, M. D., Chiveli, M. Á., et al. (2017) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.11.002 · Cited by 158
Emerging fungal pathogen Candida auris evades neutrophil attack
Johnson, C. J., Davis, J. M., Huttenlocher, A., Kernien, J. F., & Nett, J. E. (2018) · mBio · doi:10.1128/mbio.01403-18 · Cited by 157 · cited 1×
“auris, phagocytose the yeasts, or release neutrophil extra‐cellular trap (NET) formation [81].”
BackgroundThe role of ‘no-touch’ automated room disinfection systems in infection prevention and control
Otter, J. A., Yezli, S., Perl, T. M., Barbut, F., & French, G. L. (2012) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.10.002 · Cited by 153
Current perspective on emergence, diagnosis and drug resistance in Candida auris
Sarma, S., & Upadhyay, S. (2017) · Infection and Drug Resistance · doi:10.2147/idr.s116229 · Cited by 146 · cited 1×
“auris, population prevalence, and environmental contamination, effectiveness of infection prevention and control, and impact on patient mortality [21,112].”
BackgroundIdentification of Drug Resistant Candida auris
Kordalewska, M., & Perlin, D. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01918 · Cited by 145
Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris
Rybak, J. M., Doorley, L. A., Nishimoto, A. T., Barker, K. S., Palmer, G. E., & Rogers, P. D. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00057-19 · Cited by 141 · cited 1×
“The number of deaths attributable to candidemia, as opposed to underlying medical conditions, may be difficult to quantify [62].”
BackgroundIsolates of the emerging pathogen Candida auris present in the UK have several geographic origins
Borman, A. M., Székely, A., & Johnson, E. M. (2016) · Medical Mycology · doi:10.1093/mmy/myw147 · Cited by 140
Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016–20171
van Schalkwyk, E., Mpembe, R. S., Thomas, J., Shuping, L., Ismail, H., Lowman, W., Karstaedt, A. S., Chibabhai, V., Wadula, J., Avenant, T., et al. (2019) · Emerging Infectious Diseases · doi:10.3201/eid2509.190040 · Cited by 137
Kim, S. H., Iyer, K. R., Pardeshi, L., Muñoz, J. F., Robbins, N., Cuomo, C. A., Wong, K. H., & Cowen, L. E. (2019) · mBio · doi:10.1128/mbio.02529-18 · Cited by 136
Johnson, C. J., Cabezas-Olcoz, J., Kernien, J. F., Wang, S. X., Beebe, D. J., Huttenlocher, A., Ansari, H., & Nett, J. E. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005884 · Cited by 133 · cited 1×
“auris may influence immunity is unknown, however biofilms formed by other Candida species resist phagocytic killing [75,76].”
BackgroundGirard, V., Mailler, S., Chetry, M., Vidal, C., Durand, G., van Belkum, A., Colombo, A. L., Hagen, F., Meis, J. F. G. M., & Chowdhary, A. (2016) · Mycoses · doi:10.1111/myc.12519 · Cited by 114
Candida auris: a global fungal public health threat
Meis, J. F. G. M., & Chowdhary, A. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30609-1 · Cited by 110 · cited 1×
“auris into the US health‐care system in different instances [38].”
BackgroundCandida auris: A Review of Recommendations for Detection and Control in Healthcare Settings
Caceres, D. H., Forsberg, K., Welsh, R. M., Sexton, D. J., Lockhart, S. R., Jackson, B. R., & Chiller, T. (2019) · Journal of Fungi · doi:10.3390/jof5040111 · Cited by 109 · cited 1×
“auris, species identification is important not only for infection control but also for treatment [99].”
BackgroundBerkow, E. L., Angulo, D., & Lockhart, S. R. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00435-17 · Cited by 103
Reales‐Calderón, J. A., Aguilera‐Montilla, N., Corbí, Á. L., Molero, G., & Gil, C. (2014) · PROTEOMICS · doi:10.1002/pmic.201300508 · Cited by 101 · cited 1×
“Candida species have developed evasion mechanisms that may circumvent the host immune response [78,79].”
BackgroundBistoni, F., Verducci, G., Perito, S., Vecchiarelli, A., Puccetti, P., Marconi, P., & Cassone, A. (1988) · Medical Mycology · doi:10.1080/02681218880000401 · Cited by 101 · cited 1×
“Candida species have developed evasion mechanisms that may circumvent the host immune response [78,79].”
BackgroundBhattacharya, S., Holowka, T., Orner, E. P., & Fries, B. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-41513-6 · Cited by 101 · cited 2×
“Analysis of genomic DNA from older cells by qPCR indicates that transient gene duplication of CDR1 and ERG11 causes the observed age‐dependent enhanced fluconazole tolerance [63].”
BackgroundAl-Siyabi, T., Busaidi, I. A., Balkhair, A., Muharrmi, Z. A., Al-Salti, M., & Adawi, B. A. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.05.016 · Cited by 100
Gaitán, A. C. R., Martínez, H., Moret, A. M., Calabuig, E., Tasias, M., Alastruey‐Izquierdo, A., Zaragoza, Ó., Mollar, J., Frasquet, J., Salavert, M., et al. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1592675 · Cited by 98 · cited 1×
“Switching to, or adding, liposomal amphotericin B or isavuconazole could be considered, when no clinical response or persistent fungemia for > 5 days is observed [94,95].”
BackgroundDonor-Derived Transmission of Candida auris During Lung Transplantation
Azar, M. M., Turbett, S. E., Fishman, J. A., & Pierce, V. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix460 · Cited by 97 · cited 1×
“auris during lung transplantation was also described [88].”
BackgroundCandida auris in South Africa, 2012–2016
Govender, N. P., Magobo, R. E., Mpembe, R., Mhlanga, M., Matlapeng, P., Corcoran, C., Govind, C., Lowman, W., Senekal, M., & Thomas, J. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2411.18-0368 · Cited by 96
Reboli, A. C., Shorr, A. F., Rotstein, C., Pappas, P. G., Kett, D. H., Schlamm, H. T., Reisman, A. L., Biswas, P., & Walsh, T. J. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-261 · Cited by 94 · cited 1×
“The echinocandins demonstrate significant fungicidal activity against most Candida species [90].”
BackgroundKohlenberg, A., Struelens, M. J., Monnet, D. L., Plachouras, D., & The Candida auris survey collaborative group (2018) · Eurosurveillance · doi:10.2807/1560-7917.es.2018.23.13.18-00136 · Cited by 92
Wasi, M., Khandelwal, N. K., Moorhouse, A. J., Nair, R., Vishwakarma, P., Bravo Ruiz, G., Ross, Z. K., Lorenz, A., Rudramurthy, S. M., Chakrabarti, A., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01445 · Cited by 89
Biofilm formation by Candida auris isolated from colonising sites and candidemia cases
Singh, R., Kaur, M., Chakrabarti, A., Shankarnarayan, S. A., & Rudramurthy, S. M. (2019) · Mycoses · doi:10.1111/myc.12947 · Cited by 86
Sexton, D. J., Kordalewska, M., Bentz, M. L., Welsh, R. M., Perlin, D. S., & Litvintseva, A. P. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01337-18 · Cited by 84
Sharma, C., Kumar, N., Meis, J. F. G. M., Pandey, R., & Chowdhary, A. (2015) · Genome Announcements · doi:10.1128/genomea.00722-15 · Cited by 79
Pathirana, R. U., Friedman, J., Norris, H. L., Salvatori, O., McCall, A. D., Kay, J. G., & Edgerton, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01872-17 · Cited by 75
Rapid Detection of Candida auris Based on Loop-Mediated Isothermal Amplification (LAMP)
Yamamoto, M., Alshahni, M. M., Tamura, T., Satoh, K., Iguchi, S., Kikuchi, K., Mimaki, M., & Makimura, K. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00591-18 · Cited by 75
Sexton, D. J., Bentz, M. L., Welsh, R. M., & Litvintseva, A. P. (2018) · Mycoses · doi:10.1111/myc.12817 · Cited by 72
Candida auris: An emerging pathogen “incognito”?
Nett, J. E. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007638 · Cited by 69 · cited 2×
“This prompts the question of an altered fungal component that is shared for the two species, but divergent from more distantly related Candida species [84].”
BackgroundFirst reported case of multidrug-resistant Candida auris in Canada
Schwartz, I., & Hammond, G. (2017) · Canada Communicable Disease Report · doi:10.14745/ccdr.v43i78a02 · Cited by 67
Experimental mouse models of disseminated Candida auris infection
Xin, H., Mohiuddin, F., Tran, J., Adams, A., & Eberle, K. (2019) · mSphere · doi:10.1128/msphere.00339-19 · Cited by 67 · cited 2×
“auris in several immunocompetent animal models suggests that this species may withstand host immune responses that are typically sufficient to prevent invasive disease caused by other Candida species [82].”
BackgroundCandida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs
Romera, D., Aguilera-Correa, J. J., Gadea, I., Viñuela-Sandoval, L., García-Rodríguez, J., & Esteban, J. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001036 · Cited by 67 · cited 1×
“auris biofilms did not show susceptibility to any antifungal agent, showing minimal biofilm eradication concentration (MBECs) that were up to 512‐fold higher than the minimal inhibitory concentrations (MICs) [74].”
BackgroundHou, X., Lee, A., Jiménez-Ortigosa, C., Kordalewska, M., Perlin, D. S., & Zhao, Y. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01811-18 · Cited by 66 · cited 1×
“A duplex ERG11 assay and a simplex FKS1 HS1 assay were developed to identify the most prominent resistance‐ associated mutations concerning resistance to azoles and echinocandins, respectively [111].”
MethodKumar, A., Prakash, A., Singh, A., Kumar, H., Hagen, F., Meis, J. F., & Chowdhary, A. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.49 · Cited by 64 · cited 1×
“pseudohaemulonii represent an emerging clade of invasive fungal pathogens, all displaying a multidrug‐resistant (MDR) profile, most commonly to amphotericin B and also reduced susceptibility to azoles and echinocandins [59].”
BackgroundLockhart, S. R., Jackson, B. R., Vallabhaneni, S., Ostrosky-Zeichner, L., Pappas, P. G., & Chiller, T. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01355-17 · Cited by 61 · cited 1×
“Laboratories should also review past records to identify confirmed or suspected cases, as well as conduct prospective surveillance [98].”
BackgroundJohnson, C. J., Kernien, J. F., Hoyer, A. R., & Nett, J. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-13588-6 · Cited by 58 · cited 1×
“auris may influence immunity is unknown, however biofilms formed by other Candida species resist phagocytic killing [75,76].”
BackgroundThe global challenge of Candida auris in the intensive care unit
Cortegiani, A., Misseri, G., Giarratano, A., Bassetti, M., & Eyre, D. (2019) · Critical Care · doi:10.1186/s13054-019-2449-y · Cited by 54 · cited 1×
“Skin and environmental/equipment decontamination should be performed to prevent ongoing transmission [55].”
BackgroundPark, J. Y., Bradley, N. E., Brooks, S., Burney, S., & Wassner, C. (2019) · Emerging infectious diseases · doi:10.3201/eid2503.180927 · Cited by 49
Arastehfar, A. A., Fang, W., Daneshnia, F., Al‐Hatmi, A. M. S., Liao, W., Pan, W., Khan, Z., Ahmad, S., Rosam, K., Lackner, M., et al. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0227 · Cited by 47
Ahmad, A., Spencer, J. E., Lockhart, S. R., Singleton, S., Petway, D. J., Bagarozzi, D. A., & Herzegh, O. T. (2019) · Mycoses · doi:10.1111/myc.12907 · Cited by 43
The Epidemiology and Prevention of Candida auris
Snyder, G. M., & Wright, S. B. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0675-8 · Cited by 37 · cited 2×
“This suggests that a community reservoir may be unlikely; transmission to contacts in the healthcare settings is a significant risk that may depend on colonization density [44].”
BackgroundMartínez-Murcia, A., Navarro, A., Bru, G., Chowdhary, A., Hagen, F., & Meis, J. F. G. M. (2018) · Mycoses · doi:10.1111/myc.12834 · Cited by 36
Potential transmission pathways of clinically relevant fungi in indoor swimming pool facilities
Ekowati, Y., Ferrero, G., Kennedy, M. D., Husman, A. M. D. R., & Schets, F. M. (2018) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2018.07.013 · Cited by 35 · cited 2×
“auris, not restricted to hospital environment [46].”
BackgroundKim, S. H., Iyer, K. R., Pardeshi, L., Muñoz, J. F., Robbins, N., Cuomo, C. A., Wong, K. H., & Cowen, L. E. (2019) · mBio · doi:10.1128/mbio.00346-19 · Cited by 28
Jung, J., Kim, M. J., Kim, J., Lee, J.-Y., Kwak, S. H., Hong, M. J., Chong, Y. P., Lee, S., Choi, S., Kim, Y. S., et al. (2019) · Medical Mycology · doi:10.1093/mmy/myz020 · Cited by 27
Global warming “heating up” the ICU through Candida auris infections: the climate changes theory
Misseri, G., Ippolito, M., & Cortegiani, A. (2019) · Critical Care · doi:10.1186/s13054-019-2702-4 · Cited by 27
Current Progress in Medical Mycology
Lopes-Bezerra, L. M., & Mora-Montes, H. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-64113-3 · Cited by 24
Global emergence of a multi-drug resistant fungal pathogen, Candida auris
Britz, E., & Govender, N. P. (2016) · Southern African Journal of Infectious Diseases · doi:10.1080/23120053.2016.1221613 · Cited by 23 · cited 1×
“The mortality rates have varied significantly among geographic regions, with risk factors ranging from the presence of invasive devices to immunocompromised conditions [43,86].”
BackgroundPérez-García, L. A., Macías-Pérez, J. R., León‐Buitimea, A., Alvarado‐Sánchez, B., Ramírez-Quijas, M. D., Navarro-Arias, M. J., & Rodríguez-Reyes, S. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-64113-3_3 · Cited by 19
Finn, T., Novikov, A., Zakin, S., Bash, E., Berman, J. G., & Ben‐Ami, R. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw194.37 · Cited by 3
Research works printed but not linked: 1
- Bruno, M., Jaeger, J.M., Kruppa, M.G., Zuchao, M., Ning Jiao, Y., Lowman, D.W., Giamarellos-Bourboulis, E.J., Williams, D.L., Chowdhary, A., and Meis, J.F. (July, January 30). Candida auris: Understanding the mechanisms of host immune response. Proceedings of the 20th Congress of the International Society for Human and Animal Mycology, Amsterdam, The Netherlands.
Cited by
Ahmad, S., & Alfouzan, W. (2021) · Microorganisms · doi:10.3390/microorganisms9040807 · Cited by 269
Candidemia and Invasive Candidiasis
McCarty, T. P., White, C. M., & Pappas, P. G. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.007 · Cited by 260
“12 Early identification and involvement of hospital epidemiology and infection prevention are crucial to prevent spread in a hospital environment.”
First Candida auris Outbreak during a COVID-19 Pandemic in a Tertiary-Care Center in Lebanon
Allaw, F., Kara Zahreddine, N., Ibrahim, A., Tannous, J., Taleb, H., Bizri, A. R., Dbaibo, G., & Kanj, S. S. (2021) · Pathogens · doi:10.3390/pathogens10020157 · Cited by 141
Chakrabarti, A., & Sood, P. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001318 · Cited by 133
“The antimicrobial stewardship team also plays a crucial role in checking unnecessary antibiotic and antifungal use, rapid case identification, appropriate management of cases, and coordinating with the infection control team to limit transmission [110, 111].”
Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor
Jallow, S., & Govender, N. P. (2021) · Journal of Fungi · doi:10.3390/jof7030163 · Cited by 129
Metadata
- Authors
- Sabino, R., Veríssimo, C., Pereira, Á. A., & Antunes, F.
- Affiliations
- University of Lisbon (PT)
- Corresponding author
- Sabino, Raquel
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2020-01-28
- Volume
- 8
- Issue
- 2
- Pages
- 181
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC7074697
- OpenAlex
- W3003585973
- Cited by
- 133
- References
- 106
- Citations by year
- 2026: 10 · 2025: 27 · 2024: 19 · 2023: 27 · 2022: 16 · 2021: 26 · 2020: 7
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- Candida auris, nosocomial transmission, infection control, multidrug resistance, environmental contamination, hospital surfaces, climate change, fungal ecology, patient mortality, emerging fungal pathogens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.